Market Exclusive

Analyst Downgrades – La Jolla Pharmaceutical (NASDAQ:LJPC) Stock Gets Downgraded By Jefferies Group from Buy to Underperform

Analyst Ratings For La Jolla Pharmaceutical (NASDAQ:LJPC)

Today, La Jolla Pharmaceutical (NASDAQ:LJPC) stock was downgraded by Jefferies Group from Buy to Underperform.

Some recent analyst ratings include


Recent Trading Activity for La Jolla Pharmaceutical (NASDAQ:LJPC)
Shares of La Jolla Pharmaceutical closed the previous trading session at 34.52 down -2.31 6.27% with 297278 shares trading hands.

Exit mobile version